| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000040514 |
| Receipt No. | R000046121 |
| Scientific Title | Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomy |
| Date of disclosure of the study information | 2020/07/01 |
| Last modified on | 2021/05/28 (Ver. 2) |
| Basic information | ||
| Public title | Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomy | |
| Acronym | Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomy | |
| Scientific Title | Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomy | |
| Scientific Title:Acronym | Evaluation of gastroesophageal reflux using high-resolution manometry and pH monitor after proximal gastrectomy | |
| Region |
|
|
| Condition | |||
| Condition | gastric cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the esophageal reflux after proximal gastrectomy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The difference of internal pressure at the anastomotic site between the types of reconstructions at more than 1 year after proximal gastrectomy. |
| Key secondary outcomes | The difference of DeMeester score between the types of reconstructions at more than 1 year after surgery.
The change of internal pressure and DeMeester score before and after proximal gastrectomy. The associations between internal pressure or DeMeester score and quality of life. The associations between internal pressure or DeMeester score and body weight change or prognostic nutritional index. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | <Patients after proximal gastrectomy>
1) Patients who underwent proximal gastrectomy for gastric cancer at the University of Tokyo hospital 2) Patients who are 20-85 years old at the time of consent 3) Patients who do not receive chemotherapy or radiotherapy 4) Patients without recurrence 5) Patients who do not have other malignancy 6) Patients who are not hospitalized 7) Patients with the written consent <Preoperative patients> 1) Patients with gastric cancer who is planed to perform proximal gastrectomy and do not receive neoadjuvant treatment. 2) Patients who are 20-85 years old at the time of consent 3) Patients without other organ malignancy 4) Patients who are not hospitalized 5) Patients with the written consent |
|||
| Key exclusion criteria | 1) Patients within 1 year after proximal gastrectomy (except preoperative patients)
2) Patients who are expected to be difficult to complete the examination 3) Patients who can not suspend anti-acid drugs. 4) Patients who have already joined this trial 5) Patients with contraindication for esophagogastroduodenoscopy. a) hemodynamic and respiratory instability b) hemorrhagic (except anti-coagulant drugs) c) severe anastomotic stenosis d) stenosis or obstruction of the bowel distal to the duodenum e) intolerant to esophagogastroduodenoscopy 6) Patients who have difficulty in swallowing with the catheter inserted 7) Patients with allergy to the drugs we plan to use 8) Patients who are pregnant 9) Patients whom researchers regard as invalid |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastrointestinal Surgery | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| hyamashi-tky@umin.net | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, The University of Tokyo | ||||||
| Division name | Department of Gastrointestinal Surgery | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| toriumi-tky@umin.ac.jp | |||||||
| Sponsor | |
| Institute | The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Office for Human Research Studies, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| Tel | 03-5841-0818 |
| ethics@m.u-tokyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046121 |